WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Evaluation S... China's NHSA released a notification titled "Notice on Further Improving the Drug Pricing and Procurement Credit Evaluation System." This directive aims to strengthen ove...
(6/5/2025)

China's AI Healthcare Market (Part II): Opport... (6/12/2025)

China's AI Healthcare Market (Part I): Growth ... (6/12/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Driving Business Growth Through Investment Fun... (6/4/2025)

2025 Outlook for Medtech in China (Simon Kuche... (6/2/2025)

China's Clinical Trial Boom (Asimov Press) (5/22/2025)

'China's Ozempic' may vie with Eli Lilly, Novo... (5/20/2025)

How Trump's Proposed Price Cuts Could Hurt Chi... (5/20/2025)

US Tariffs on Pharmaceuticals Could Hit Chines... (5/16/2025)

SMEI: China's Pharmaceutical Industry Seeks St... (5/16/2025)

Recent Executive Moves (6/13/2025) China Issues 2025 Action Plan to Combat... (6/13/2025) Abbisko Therapeutics' Pimicotinib Earns ... (6/13/2025) AB‑RayBio Secures Multi‑Million CNY A... (6/13/2025) AstraZeneca Enters Strategic Deal with C... (6/13/2025) Nona and Visterra Partner to Advance Nex... (6/13/2025) Kelun Cleared for Clinical Trial of SKB3... (6/13/2025) Viatris Wins NMPA Approval for Once‑Dai... (6/12/2025) Hengrui Advances DLL3‑Targeting ADC SHR... (6/12/2025) CF PharmaTech Files for Hong Kong IPO (6/12/2025) Dizal to Showcase Breakthrough Data on H... (6/12/2025) Cloudbreak Advances Ophthalmic Pipeline,... (6/12/2025) InnoVec Raises Tens of Millions in Serie... (6/12/2025) MediLink Therapeutics Lines Up Major Ban... (6/11/2025) JW Pharma Wins China Approval for Ertape... (6/11/2025) Ligachem Inks Dual ADC Licensing Deals w... (6/11/2025) 3Sbio Powers Ahead in PD-1/VEGF Bispecif... (6/11/2025) BIOSeedin 2025 Showcases China's Rise as... (6/10/2025)

NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-...

Nona and Visterra Partner to Advance Next-Gen Biotherap... AstraZeneca Enters Strategic Deal with CSPC Pharma Focu... AB‑RayBio Secures Multi‑Million CNY Angel Investment Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TG... InnoVec Raises Tens of Millions in Series A+ to Acceler...

CDE Seeks Public Feedback on Second Batch of 2025 Exter... CDE Seeks Comments on Draft Guidelines for Defining and... CDE Solicits Comments on Draft Guidance on Post-Approva... NMPA Reopens Comment on Draft Announcement for Strength... NMPA Issues New Regulations on Experimental Research of...

China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official China Expands Geriatric Services at Major Hospitals as ... China's BMI Fund Reports Big Surplus in Q1/2025

Gavi Launches $224M Arbitration Claim Against Clover Bi... AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ... State Council Approves Draft Medical Security Law, Stre... Novo Nordisk Sues KBP Biosciences for $830 Million Over...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Kelun Cleared for Clinical Trial of SKB315 and Tagitanl... Dizal to Showcase Breakthrough Data on Hematologic Onco... Viatris Wins NMPA Approval for Once‑Daily Nebulized CO... 3Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Im... JW Pharma Wins China Approval for Ertapenem Injection

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati... Recent Official and Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...